Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 155
2
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can we find a low cost solution to store temperature sensitive enzymes in research?

Temperature-sensitive reagents are common in biology labs, and often need to be stored in expensive ultra...

Which Human Physical Aging Biomarkers Validate Genetic and Biochemical Aging Reversal Success?

Harvard Medical School has reported successful aging reversal using genetic and biochemical methods in the...

Does Zika virus suppress the antiviral host response in neuronal cells?

Zika virus is spreading rapidly in the Western hemisphere and is linked to fetal microcephaly. We recently...

Backer Badge Funded